A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

Waterfowl birds and their predators are especially at risk of contracting H5N1. Massachusetts has not yet reported a human ...

As more cases of bird flu emerge across the country, public health leaders in New York City are watching warily -- and making ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

Another late-2024 study found that viral shedding, the expulsion of viral particles, in the air related to transmissibility ...

The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...

Last year, Moderna completed a Phase I/II clinical trial of an investigational influenza vaccine called mRNA-1018, which was tested against H5 and H7 bird flu subtypes. The company said in a Jan. 17 ...

Erica Denhoff / Icon Sportswire via Getty Images Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu. The biotech ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

Moderna is working with the Department of Health and Human Services to develop a vaccine to combat bird flu. Human to human transmission has not yet been reported.